Mr. Alain Masson has served as Deputy Chief Executive Officer and Pharmacist Manager of Vetoquinol SA as of April 1, 2008. He is also Quality Director of the Group since 2008. He holds a Doctorate in Pharmacy from the Universite de FrancheComte and obtained a postgraduate degree in Industrial Pharmacy majoring in cosmetology, Lyon . He began his career in the pharmaceutical industry in 1988 at Vetoquinol Laboratories, as head of quality control. He has held the positions of Quality Assurance manager, Head of Quality and Group Industrial Quality Manager, France. Since 2008, he was in charge of the Group overall Quality at industrial sites, at the distribution subsidiaries and the R&D centers. He is Vice Chairman of GMP IFAH Europe.
The company has return on total asset (ROA) of 5.97 % which means that it generated profit of $5.97 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 10.28 % meaning that it generated $10.28 on every $100 dollars invested by stockholders.
The company has accumulated 50.39 M in total debt with debt to equity ratio (D/E) of 0.22 which may suggest the company is not taking enough advantage from borrowing. V has Current Ratio of 2.06 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
V?toquinol S.A., a veterinary pharmaceutical laboratory, engages in the development, production, and marketing of veterinary medicines and nonmedicinal products. V [VETO] is traded on Paris Stock Exchange in France. It is located in Lure, and employs 1,812 people. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
Paris V
-1.39% 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
